Hilary Zetlen1, Kenn B Daratha2, Jonathan D Harper1, Hunter Wessells1, Kenneth P Roberts3, John L Gore4. 1. Department of Urology, University of Washington School of Medicine, Seattle, WA. 2. College of Nursing, Washington State University, Spokane, WA. 3. College of Medical Sciences, Washington State University, Spokane, WA. 4. Department of Urology, University of Washington School of Medicine, Seattle, WA. Electronic address: jlgore@u.washington.edu.
Abstract
OBJECTIVE: To examine hospital-level variation in outcomes following benign urologic surgeries given that hospital-level variation in surgical outcomes can portend quality and appropriateness of care concerns and identify quality improvement opportunities in perioperative care. MATERIALS AND METHODS: Using the Washington State Comprehensive Hospital Abstract Reporting System, we identified patients who underwent transurethral resection of the prostate (TURP), percutaneous nephrostolithotomy (PCNL), and pyeloplasty from 2003 to 2008. We classified prolonged postoperative length of stay (LOS) as that exceeding the 75th percentile, and we measured the rate of Agency for Healthcare Quality Patient Safety Indicators, readmissions, and death. We calculated hospital-specific observed-to-expected event rates using random effects multilevel multivariable models adjusted for age and comorbidity. RESULTS: We identified 6699 TURP patients at 54 hospitals, 2541 PCNL patients at 45 hospitals, and 584 pyeloplasty patients at 36 hospitals. Complication rates were highest after PCNL (22.9% prolonged LOS vs 17.3% for TURP and 13.9% for pyeloplasty, P < .001; 3.4% 90-day mortality vs 0.6% for TURP and 0% for pyeloplasty). Hospital-level variation was most substantial for LOS after TURP and pyeloplasty (8.1% and 14.3% of variance in prolonged LOS, respectively). CONCLUSION: Hospital-level variation is common after benign inpatient urologic surgeries and may relate to difference in perioperative provider practice patterns. The morbidity of PCNL in this study was higher than expected and merits further investigation.
OBJECTIVE: To examine hospital-level variation in outcomes following benign urologic surgeries given that hospital-level variation in surgical outcomes can portend quality and appropriateness of care concerns and identify quality improvement opportunities in perioperative care. MATERIALS AND METHODS: Using the Washington State Comprehensive Hospital Abstract Reporting System, we identified patients who underwent transurethral resection of the prostate (TURP), percutaneous nephrostolithotomy (PCNL), and pyeloplasty from 2003 to 2008. We classified prolonged postoperative length of stay (LOS) as that exceeding the 75th percentile, and we measured the rate of Agency for Healthcare Quality Patient Safety Indicators, readmissions, and death. We calculated hospital-specific observed-to-expected event rates using random effects multilevel multivariable models adjusted for age and comorbidity. RESULTS: We identified 6699 TURP patients at 54 hospitals, 2541 PCNL patients at 45 hospitals, and 584 pyeloplasty patients at 36 hospitals. Complication rates were highest after PCNL (22.9% prolonged LOS vs 17.3% for TURP and 13.9% for pyeloplasty, P < .001; 3.4% 90-day mortality vs 0.6% for TURP and 0% for pyeloplasty). Hospital-level variation was most substantial for LOS after TURP and pyeloplasty (8.1% and 14.3% of variance in prolonged LOS, respectively). CONCLUSION: Hospital-level variation is common after benign inpatient urologic surgeries and may relate to difference in perioperative provider practice patterns. The morbidity of PCNL in this study was higher than expected and merits further investigation.
Authors: David M Shahian; David F Torchiana; Richard J Shemin; James D Rawn; Sharon-Lise T Normand Journal: Ann Thorac Surg Date: 2005-12 Impact factor: 4.330
Authors: Khurshid R Ghani; Jesse D Sammon; Naeem Bhojani; Pierre I Karakiewicz; Maxine Sun; Shyam Sukumar; Ray Littleton; James O Peabody; Mani Menon; Quoc-Dien Trinh Journal: J Urol Date: 2013-02-19 Impact factor: 7.450
Authors: Shyam Sukumar; Maxine Sun; Pierre I Karakiewicz; Ariella A Friedman; Felix K Chun; Jesse Sammon; Khurshid R Ghani; Praful Ravi; Marco Bianchi; Wooju Jeong; Shahrokh F Shariat; Jens Hansen; James O Peabody; Jack S Elder; Mani Menon; Quoc-Dien Trinh Journal: J Urol Date: 2012-07-20 Impact factor: 7.450
Authors: John L Gore; Jonathan L Wright; Kenn B Daratha; Kenneth P Roberts; Daniel W Lin; Hunter Wessells; Michael Porter Journal: Cancer Date: 2011-07-26 Impact factor: 6.860
Authors: Colin B Begg; Elyn R Riedel; Peter B Bach; Michael W Kattan; Deborah Schrag; Joan L Warren; Peter T Scardino Journal: N Engl J Med Date: 2002-04-11 Impact factor: 91.245
Authors: Bruce L Jacobs; Samuel R Kaufman; Hal Morgenstern; Brent K Hollenbeck; J Stuart Wolf; John M Hollingsworth Journal: J Endourol Date: 2012-11-07 Impact factor: 2.942
Authors: Daniel J Kagedan; Nik Goyert; Qing Li; Lawrence Paszat; Alexander Kiss; Craig C Earle; Paul J Karanicolas; Alice C Wei; Nicole Mittmann; Natalie G Coburn Journal: J Gastrointest Surg Date: 2017-01-05 Impact factor: 3.452